Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 79

1.

Development of eosinophilic fasciitis during treatment with certolizumab pegol for ankylosing spondylitis.

Debusschere C, De Schepper S, Piette Y, Vanhaecke A, Verbist C, Smith V.

Clin Exp Rheumatol. 2020 Apr 3. [Epub ahead of print] No abstract available.

PMID:
32242807
2.

Pitfalls in the detection of myositis specific antibodies by lineblot in clinically suspected idiopathic inflammatory myopathy.

Piette Y, De Sloovere M, Vandendriessche S, Dehoorne J, De Bleecker JL, Van Praet L, Vander Mijnsbrugge AS, De Schepper S, Jacques P, De Keyser F, Smith V, Bonroy C.

Clin Exp Rheumatol. 2020 Mar-Apr;38(2):212-219. Epub 2019 Jul 4.

PMID:
31287411
3.

Idiopathic inflammatory myopathies: state of the art on clinical practice guidelines [corrected].

Meyer A, Scirè CA, Talarico R, Alexander T, Amoura Z, Avcin T, Barsotti S, Beretta L, Blagojevic J, Burmester G, Cavazzana I, Cherrin P, Damian L, Doria A, Fonseca JE, Furini F, Galetti I, Houssiau F, Krieg T, Maddalena L, Launay D, Campanilho-Marques R, Martin T, Matucci-Cerinic M, Moinzadeh P, Montecucco C, Moraes-Fontes MF, Mouthon L, Neri R, Paolino S, Piette Y, Rednic S, Tamirou F, Tincani A, Toplak N, Bombardieri S, Hachulla E, Mueller-Ladner U, Schneider M, Smith V, Vieira A, Cutolo M, Mosca M, Cavagna L.

RMD Open. 2019 Feb 26;4(Suppl 1):e000784. doi: 10.1136/rmdopen-2018-000784. eCollection 2018. Review. Erratum in: RMD Open. 2019 Apr 15;5(1):e000784corr1.

4.

Autoantibodies in idiopathic inflammatory myopathies: Clinical associations and laboratory evaluation by mono- and multispecific immunoassays.

Damoiseaux J, Vulsteke JB, Tseng CW, Platteel ACM, Piette Y, Shovman O, Bonroy C, Hamann D, De Langhe E, Musset L, Chen YH, Shoenfeld Y, Allenbach Y, Bossuyt X.

Autoimmun Rev. 2019 Mar;18(3):293-305. doi: 10.1016/j.autrev.2018.10.004. Epub 2019 Jan 11. Review.

5.

RORγt inhibition selectively targets IL-17 producing iNKT and γδ-T cells enriched in Spondyloarthritis patients.

Venken K, Jacques P, Mortier C, Labadia ME, Decruy T, Coudenys J, Hoyt K, Wayne AL, Hughes R, Turner M, Van Gassen S, Martens L, Smith D, Harcken C, Wahle J, Wang CT, Verheugen E, Schryvers N, Varkas G, Cypers H, Wittoek R, Piette Y, Gyselbrecht L, Van Calenbergh S, Van den Bosch F, Saeys Y, Nabozny G, Elewaut D.

Nat Commun. 2019 Jan 2;10(1):9. doi: 10.1038/s41467-018-07911-6.

6.

A prospective, longitudinal study evaluating the baseline six-minute walk test as an individual reference value in systemic sclerosis patients.

Vandecasteele E, Melsens K, De Keyser F, De Pauw M, Deschepper E, Decuman S, Piette Y, Thevissen K, Brusselle G, Smith V.

Clin Exp Rheumatol. 2018 Jul-Aug;36 Suppl 113(4):95-101. Epub 2018 Aug 28.

PMID:
30183593
7.

Is laser speckle contrast analysis (LASCA) the new kid on the block in systemic sclerosis? A systematic literature review and pilot study to evaluate reliability of LASCA to measure peripheral blood perfusion in scleroderma patients.

Cutolo M, Vanhaecke A, Ruaro B, Deschepper E, Ickinger C, Melsens K, Piette Y, Trombetta AC, De Keyser F, Smith V; EULAR Study Group on Microcirculation in Rheumatic Diseases.

Autoimmun Rev. 2018 Aug;17(8):775-780. doi: 10.1016/j.autrev.2018.01.023. Epub 2018 Jun 6. Review.

PMID:
29885540
8.

Association of Inflammatory Bowel Disease and Acute Anterior Uveitis, but Not Psoriasis, With Disease Duration in Patients With Axial Spondyloarthritis: Results From Two Belgian Nationwide Axial Spondyloarthritis Cohorts.

Varkas G, Vastesaeger N, Cypers H, Colman R, Renson T, Praet LV, Carron P, Raeman F, Devinck M, Gyselbrecht L, Corluy L, Piette Y, Lenaerts J, Thevissen K, Vanneuville B, Bosch FVD, Elewaut D.

Arthritis Rheumatol. 2018 Oct;70(10):1588-1596. doi: 10.1002/art.40551.

9.

Nailfold capillaroscopy in systemic lupus erythematosus: A systematic review and critical appraisal.

Cutolo M, Melsens K, Wijnant S, Ingegnoli F, Thevissen K, De Keyser F, Decuman S, Müller-Ladner U, Piette Y, Riccieri V, Ughi N, Vandecasteele E, Vanhaecke A, Smith V.

Autoimmun Rev. 2018 Apr;17(4):344-352. doi: 10.1016/j.autrev.2017.11.025. Epub 2018 Feb 8. Review.

PMID:
29427827
10.

The importance of detecting anti-DFS70 in routine clinical practice: comparison of different care settings.

Bonroy C, Schouwers S, Berth M, Stubbe M, Piette Y, Hoffman I, Devreese K, Van Hoovels L.

Clin Chem Lab Med. 2018 Jun 27;56(7):1090-1099. doi: 10.1515/cclm-2017-0541.

PMID:
29427547
11.

Two years follow-up of an open-label pilot study of treatment with rituximab in patients with early diffuse cutaneous systemic sclerosis.

Melsens K, Vandecasteele E, Deschepper E, Badot V, Blockmans D, Brusselle G, De Langhe E, De Pauw M, Debusschere C, Decuman S, Deroo L, Houssiau F, Lenaerts J, Piette Y, Thevissen K, Vanthuyne M, Westhovens R, Wijnant S, De Keyser F, Smith V.

Acta Clin Belg. 2018 Apr;73(2):119-125. doi: 10.1080/17843286.2017.1372244. Epub 2017 Sep 11.

PMID:
28891418
12.

Screening for pulmonary arterial hypertension in an unselected prospective systemic sclerosis cohort.

Vandecasteele E, Drieghe B, Melsens K, Thevissen K, De Pauw M, Deschepper E, Decuman S, Bonroy C, Piette Y, De Keyser F, Brusselle G, Smith V.

Eur Respir J. 2017 May 11;49(5). pii: 1602275. doi: 10.1183/13993003.02275-2016. Print 2017 May.

13.

Six-minute walk test in or out in evaluation of systemic sclerosis patients?

Vandecasteele E, Thevissen K, Melsens K, De Keyser F, De Pauw M, Deschepper E, Decuman S, Piette Y, Brusselle G, Smith V.

Clin Exp Rheumatol. 2017 Sep-Oct;35 Suppl 106(4):122-129. Epub 2017 Feb 15.

PMID:
28229829
14.

Assessment of sensitivity to change of the European Scleroderma Study Group activity index.

Melsens K, De Keyser F, Decuman S, Brusselle G, De Pauw M, Deschepper E, De Wilde K, Elewaut D, Piette Y, Vandecasteele E, Smith V.

Clin Exp Rheumatol. 2016 Sep-Oct;34 Suppl 100(5):148-151. Epub 2016 Jul 18.

PMID:
27463733
15.

Disease activity indices in systemic sclerosis: a systematic literature review.

Melsens K, De Keyser F, Decuman S, Piette Y, Vandecasteele E, Smith V.

Clin Exp Rheumatol. 2016 Sep-Oct;34 Suppl 100(5):186-192. Epub 2016 Jul 6. Review.

16.

Anakinra in resistant gout: a case report.

Van Wabeke J, Dhondt E, Peene I, Piette Y.

Acta Clin Belg. 2017 Aug;72(4):293-295. doi: 10.1080/17843286.2016.1239891. Epub 2016 Oct 7.

PMID:
27712511
17.

Stabilization of Microcirculation in Patients with Early Systemic Sclerosis with Diffuse Skin Involvement following Rituximab Treatment: An Open-label Study.

Smith V, Pizzorni C, Riccieri V, Decuman S, Brusselle G, DE Pauw M, Deschepper E, Piette Y, Ruaro B, Sulli A, Vandecasteele E, Melsens K, DE Keyser F, Cutolo M.

J Rheumatol. 2016 May;43(5):995-6. doi: 10.3899/jrheum.151018. No abstract available.

PMID:
27134280
18.

Nailfold Capillaroscopy and Clinical Applications in Systemic Sclerosis.

Smith V, Thevissen K, Trombetta AC, Pizzorni C, Ruaro B, Piette Y, Paolino S, De Keyser F, Sulli A, Melsens K, Cutolo M; EULAR Study Group on Microcirculation in Rheumatic Diseases.

Microcirculation. 2016 Jul;23(5):364-72. doi: 10.1111/micc.12281. Review.

PMID:
27086648
19.

The heart and pulmonary arterial hypertension in systemic sclerosis.

Vandecasteele EH, De Pauw M, Brusselle G, Decuman S, Piette Y, De Keyser F, Smith V.

Acta Clin Belg. 2016 Feb;71(1):1-18. doi: 10.1080/17843286.2015.1108538. Epub 2016 Feb 5. Review.

PMID:
27075793
20.

Six-minute walk test in systemic sclerosis: A systematic review and meta-analysis.

Vandecasteele E, De Pauw M, De Keyser F, Decuman S, Deschepper E, Piette Y, Brusselle G, Smith V.

Int J Cardiol. 2016 Jun 1;212:265-73. doi: 10.1016/j.ijcard.2016.03.084. Epub 2016 Mar 25. Review.

PMID:
27057932
21.

IgG4-related disease: The utility of (18)F-FDG PET/CT in diagnosis and treatment.

Lauwyck J, Piette Y, Van Walleghem L, De Geeter F.

Hell J Nucl Med. 2015 Sep-Dec;18 Suppl 1:155-9.

PMID:
26672716
22.

Nailfold capillaroscopy for prediction of novel future severe organ involvement in systemic sclerosis.

Smith V, Riccieri V, Pizzorni C, Decuman S, Deschepper E, Bonroy C, Sulli A, Piette Y, De Keyser F, Cutolo M.

J Rheumatol. 2013 Dec;40(12):2023-8. doi: 10.3899/jrheum.130528. Epub 2013 Oct 15.

PMID:
24128778
23.

Two-year results of an open pilot study of a 2-treatment course with rituximab in patients with early systemic sclerosis with diffuse skin involvement.

Smith V, Piette Y, van Praet JT, Decuman S, Deschepper E, Elewaut D, De Keyser F.

J Rheumatol. 2013 Jan;40(1):52-7. doi: 10.3899/jrheum.120778. Epub 2012 Nov 1.

PMID:
23118116
24.

Key role of intramolecular metal chelation and hydrogen bonding in the cobalt-mediated radical polymerization of N-vinyl amides.

Debuigne A, Morin AN, Kermagoret A, Piette Y, Detrembleur C, Jérôme C, Poli R.

Chemistry. 2012 Oct 1;18(40):12834-44. doi: 10.1002/chem.201201456. Epub 2012 Aug 21.

PMID:
22907863
25.

Correlative imaging in crowned dens syndrome.

De Geeter F, Goethals L, Piette Y, De Neve J, Ghekiere J.

Clin Nucl Med. 2007 Nov;32(11):854-7. No abstract available.

PMID:
18075419
26.

Supported cobalt mediated radical polymerization (SCMRP) of vinyl acetate and recycling of the cobalt complex.

Sciannamea V, Debuigne A, Piette Y, Jerome R, Detrembleur C.

Chem Commun (Camb). 2006 Oct 28;(40):4180-2. Epub 2006 Sep 20.

27.

[Value and limitations of the infrared laser in arthroses and periarthroses. 12 April 1986 report to the Belgian Society of Physical Medicine].

Piette F, Henrard A, Piette Y.

Acta Belg Med Phys. 1987 Oct-Dec;10(4):139-48. French. No abstract available.

PMID:
2963471
28.

Acetate metabolism and bicarbonate generation during hemodialysis: 10 years of observation.

Vinay P, Prud'Homme M, Vinet B, Cournoyer G, Degoulet P, Leville M, Gougoux A, St-Louis G, Lapierre L, Piette Y.

Kidney Int. 1987 May;31(5):1194-204.

29.

Advantages and limits of I.R. laser in arthrosis and periarthrosis. Clinical and technological aspects.

Piette F, Henrard A, Piette Y.

Acta Belg Med Phys. 1987 Apr-Jun;10(2):69. No abstract available.

PMID:
2960114
30.

The acid-base status does not influence the rate of acetate metabolism in hemodialyzed patients.

Vinay P, Prud'homme M, Vinet B, Gougoux A, Léveillée M, St-Louis G, Lapierre L, Piette Y.

Clin Invest Med. 1986;9(3):160-6.

PMID:
3757322
31.

[Applications of computer technology to the monitoring of patients treated by periodic hemodialysis].

Degoulet P, Marichal JF, Cournoyer G, Meloche H, Lapierre L, Piette Y.

Union Med Can. 1976 Aug;105(8):1217-22. French. No abstract available.

PMID:
982708
32.

[Oxaloacetic transaminase, lactate dehydrogenase, alkaline phosphatase and bilirubin in patients on chronic hemodialysis].

Degoulet P, Rahmi R, Piette Y.

Union Med Can. 1973 Aug;103(8):1644-9. French. No abstract available.

PMID:
4792851
33.

Urinary tract candidiasis: report of a case with bilateral ureteral obstruction.

Béland G, Piette Y.

Can Med Assoc J. 1973 Feb 17;108(4):472 passim.

34.

[Acute renal insufficiency and ampicillin allergy].

Langlois C, Piette Y.

Union Med Can. 1971 May;100(5):936-40. French. No abstract available.

PMID:
5163011
35.

Action of topically applied atropine, eserine, acetylcholine and nicotine on cortical epilepsy in the rabbit.

Bernard PJ, Piette Y, Delaunois AL, De Schaepdryver AF.

Arch Int Pharmacodyn Ther. 1969 Feb;177(2):486. No abstract available.

PMID:
5807180
36.

[General principles for making a program to format and calculate the electrobiologic results furnished by the Computer of Average Transients (C.A. T.)].

Danthine A, Pône N, Piette Y, Deliège M, Faidherbe J.

Arch Int Physiol Biochim. 1969 Feb;77(1):119-25. French. No abstract available.

PMID:
4181684
37.

[Idiopathic hemosiderosis and glomerulonephritis. Goodpastures syndrome].

Piette Y, Lapierre L, Bettez P, Wells JP.

Union Med Can. 1968 Nov;97(11):1562-9. French. No abstract available.

PMID:
5746554
38.

[Review of various problems of obstetrical nephrology].

Lapierre L, Piette Y.

Union Med Can. 1968 Nov;97(11):1594-602. Review. French. No abstract available.

PMID:
4915621
39.

Action of atropine and atropine methylnitrate on cortical epilepsy in the rabbit.

Bernard PJ, Piette Y, Delaunois AL, De Schaepdryver AF.

Arch Int Pharmacodyn Ther. 1968 Mar;172(1):224-7. No abstract available.

PMID:
4870326
40.

[Results of hemodialysis in the treatment of acute renal insufficiency].

Lapierre L, Piette Y.

Union Med Can. 1967 Jun;96(6):653-61. French. No abstract available.

PMID:
5620767
41.

[Electroshock: an experimental and clinical study].

Piette Y.

Verh Dtsch Ges Pathol. 1967;29(1):25-88. Dutch. No abstract available.

PMID:
4170205
42.

Blood alcohol levels and psychotropic drugs.

Casier H, Danechmand L, De Schaepdryver A, Hermans W, Piette Y.

Arzneimittelforschung. 1966 Nov;16(11):1505-7. No abstract available.

PMID:
6014968
43.

Brain amines and electroshock convulsive threshold.

Heymans C, De Schaepdryver AF, Delaunois AL, Piette Y.

Indian J Physiol Pharmacol. 1964 Jul;8(3):113-6. No abstract available.

PMID:
4378575
44.

[PHARMACOLOGY OF ELECTROSHOCK].

HEYMANS C, DE SCHAEPDRYVER AF, DELAUNOIS AL, PIETTE Y.

Med Monatsschr. 1964 May;18:220-5. German. No abstract available.

PMID:
14230149
45.

[DRUGS AND ELECTROSHOCK].

HEYMANS C, DESCHAEPDRYVER AF, DELAUNOIS AL, PIETTE Y.

Riforma Med. 1964 Jan 4;78:1-6. Italian. No abstract available.

PMID:
14127208
46.

[PHEOCHROMOCYTOMA: CLINICAL POLYMORPHISM AND SURGICAL CONSIDERATIONS].

PIETTE Y, LAPIERRE L, BEIQUE L, LECLAIR M, GOULET Y, PARENT M.

Union Med Can. 1963 Dec;92:1407-10. French. No abstract available.

PMID:
14101828
47.

IMIPRAMINE AND ELECTROSHOCK THRESHOLD.

PIETTE Y, DELAUNOIS AL, DESCHAEPDRYVER AF, HEYMANS C.

Arch Int Pharmacodyn Ther. 1963 Jul 1;144:293-7. No abstract available.

PMID:
14047156
48.

[Cerebral amines and convulsive threshold in electroshock].

HEYMANS C, PIETTE Y, DELAUNOIS AL, DE SCHAEPDRYVER AF.

Ther Umsch. 1963 Mar;20:108-11. French. No abstract available.

PMID:
13954330
49.

Brain amines and electroshock threshold.

DE SCHAEPDRYVER AF, PIETTE Y, DELAUNOIS AL.

Arch Int Pharmacodyn Ther. 1962 Dec 1;140:358-67. No abstract available.

PMID:
14026056
50.

Method for electroshock threshold studies.

DELAUNOIS AL, DE SCHAEPDRYVER AF, PIETTE Y.

Arch Int Pharmacodyn Ther. 1962 Mar 1;136:242-50. No abstract available.

PMID:
13885084

Supplemental Content

Loading ...
Support Center